Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07549139

Overcoming Racial Disparities in Screening Mammography

The purpose of this study is to increase screening mammography among Black women by implementing and evaluating a culturally tailored patient-centric program designed to address barriers to screening. By performing a randomized clinical trial, this study aims to develop effective strategies to improve adherence to screening mammography and contribute to reducing health disparities in breast cancer outcomes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Cancer of the Breast Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

40 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location contact

Ashley Housten, OTD, OTR, MSCI, MPA

SUB_INVESTIGATOR

Debbie Bennett, MD

SUB_INVESTIGATOR

Foluso Ademuyiwa, MD, MPH, MSCI

CONTACT

[email protected]

314-362-5654

Foluso Ademuyiwa, MD, MPH, MSCI

PRINCIPAL_INVESTIGATOR

Shaili Tapiavala, MD

SUB_INVESTIGATOR

Ying Liu, MD, PhD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Woman
  • At least 40 years old
  • Self-identify as Black
  • English-speaking
  • Scheduled for a screening mammogram within 8 weeks of study entry
  • Able to understand and willing to sign an IRB approved written informed consent document.

Exclusion criteria

  • A previous history of breast cancer
  • Scheduled for a diagnostic mammogram
  • Has a documented or uncorrectable cognitive, hearing, or visual impairment.
  • Too ill to participate (diagnosed with or suffering from a condition that, in the judgment of the investigator, may limit participation in the study).

Treatment and study plan

Appointment mail reminder

Other

Patient will receive an appointment reminder in the mail 7-10 days prior to the appointment.

Telephone Counseling

Other

The telephone counseling will include an appointment reminder within 7 days of their appointment and identify and troubleshoot barriers to patient's mammography completion.

Digital navigation video

Other

The digital navigation video will explain the rationale for the mammogram and the mammography procedure. Digital navigation video will be sent by SMS text message 1-3 days prior to the appointment.

Automated phone call

Other

Patient will receive an automated reminder phone call for their appointment 1-3 days prior to the appointment.

Primary outcomes

  1. No-show rate

    Time frame: 6 months after randomization

    Defined as the proportion of participants who do not complete (or do not reschedule) their screening mammogram appointment within 6 months of randomization.

Study contacts

Contact information is provided by the study sponsor or research team.

Foluso Ademuyiwa, MD, MPH, MSCI

CONTACT

[email protected]

314-362-5654

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • National Comprehensive Cancer Network
  • Novartis

Registry information

Official study title

A Personalized Approach to Promote Health Equity by Overcoming Racial Disparities in Screening Mammography

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 23, 2026
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.